CYP cynata therapeutics limited

“Meanwhile a Phase 1 study in GvHD, which was published in...

  1. 8,725 Posts.
    lightbulb Created with Sketch. 1455
    “Meanwhile a Phase 1 study in GvHD, which was published in prestigious journal Nature Medicine, is probably the closest to commercialisation according to Dr Macdonald.




    Probably. Maybe. Whatever!

    You realise Ross mentioned MSB at the end of that article? And the article has Mesoblast in the title?

    At scale.


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
17.0¢
Change
0.015(9.68%)
Mkt cap ! $38.41M
Open High Low Value Volume
15.5¢ 17.0¢ 15.5¢ $47.10K 289.1K

Buyers (Bids)

No. Vol. Price($)
1 50000 16.5¢
 

Sellers (Offers)

Price($) Vol. No.
17.0¢ 23813 3
View Market Depth
Last trade - 16.10pm 27/06/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.